Life Sciences Investing

Vista Equity Partners will acquire Model N (NYSE: MODN) for approximately $1.25 billion, according to a news release.

Model N, founded in 1999 and based in San Mateo, Calif., is a provider of revenue optimization and compliance software

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Vista to Acquire Model N for $1.25 Billion

New Mountain Capital will sell ILC Dover to Ingersoll Rand for about $2.3 billion, according to industry reports.

ILC, founded in 1947 and based in Frederica, Del., designs and produces solutions for the biopharmaceutical, pharmaceutical and medical device

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: New Mountain to Sell ILC Dover for $2.3 Billion

Arsenal Capital Partners will acquire Fortrea’s enabling services segment and patient access businesses, according to a news release.

Fortea (Nasdaq: FTRE), a global clinical research organization based in Research Triangle Park, N.C., is divesting its Endpoint Clinical and Fortrea

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Arsenal Acquires Multiple Companies From Fortrea

Linden Capital Partners has announced the acquisition of Alcresta Therapeutics.

Alcresta, founded in 2011 and based in Newton, Mass., develops and commercializes enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases.

Linden

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Linden Acquires Alcresta Therapeutics

Vesey Street Capital Partners (VSCP) has announced the completion of a majority recapitalization of Inceptua Group.

Inceptua, founded in 1997 and with its U.S. office in Princeton, N.J., is provider of clinical trial supplies and related services.

VSCP

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Vesey Recaps Inceptua Group

Windjammer Capital has announced it has acquired Bio X Cell (BXC).

BXC, founded in 1997 and based in Lebanon, N.H., is a producer of monoclonal antibodies for use in both in vivo and in vitro pre-clinical research applications.

Windjammer

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Windjammer Acquires Bio X Cell

QHP Capital has announced it has acquired Applied StemCell.

Applied StemCell, founded in 2008 and based in Milpitas, Calif., develops gene editing and stem cell technology platforms designed to help advance broader cell therapy manufacturing.

QHP, based in

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: QHP Acquires Applied StemCell

Gurnet Point Capital and Novo Holdings have completed their acquisition of Paratek Pharmaceuticals in a deal valued at $462 million, according to a news release.

Paratek, founded in 1996 and based in Boston, is a commercial-stage biopharmaceutical company

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Gurnet Point and Novo Holdings Acquire Paratek Pharmaceuticals